Melt Pharmaceuticals
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR) (NCT05133518) | Melt Pharmaceuticals | 2021-07-20 |
| Relative Bioavailability Study of MELT-100, IV Midazolam, and IV Ketamine (NCT04767035) | Melt Pharmaceuticals | 2020-12-01 |
| Phase 1 Bioavailability Study of MELT-100 (Midazolam and Ketamine Sublingual) and IV Midazolam or Ketamine (NCT04485702) | Melt Pharmaceuticals | 2020-07-20 |
Track Melt Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.